BFC Planning’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$357K Buy
1,310
+1,025
+360% +$266K 0.01% 727
2026
Q2
$70.6K Buy
285
+59
+26% +$12.7K ﹤0.01% 1385
2026
Q1
$45.4K Sell
226
-9
-4% -$1.86K ﹤0.01% 1379
2025
Q4
$48.5K Sell
235
-16
-6% -$3.2K ﹤0.01% 1379
2025
Q3
$45K Hold
251
– – ﹤0.01% 1232
2025
Q2
$40.5K Sell
251
-184
-42% -$29.3K ﹤0.01% 1210
2025
Q1
$74K Hold
435
– – 0.01% 971
2024
Q4
$72.3K Buy
435
+1
+0.2% +$171 0.01% 981
2024
Q3
$74.6K Buy
+434
New +$71.8K 0.01% 975

Other funds holding FBT

BFC Planning's FBT Position: Q3 2026 in Review

BFC Planning increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 360% in Q3 2026, buying an estimated $266K and bringing the position to 1,310 shares worth $357K. The position accounts for 0.01% of the portfolio, ranked #727.

BFC Planning first reported a position in FBT in Q3 2024 and has held it in 9 quarters since. 311 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • BFC Planning held 1,310 shares of First Trust NYSE Arca Biotechnology Index Fund worth $357K as of Q3 2026.
  • BFC Planning bought 1,025 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $266K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of BFC Planning's portfolio in Q3 2026, its #727 holding.
  • BFC Planning first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2024 and has held it in 9 quarters since.
  • 311 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.